The Traderszone Network

Published in TZ Latest News 14 October, 2014 by The TZ Newswire Staff

J&J sales top forecast, helped by drug for hep C

J&J reported strong earnings, boosted by sales of a new drug for hepatitis C that are expected to evaporate in coming months due to competition.